Answer
Nausea, vomiting, application site reactions, somnolence, dizziness and headache were reported in more than 10% of patients treated with Neupro (rotigotine) transdermal patches for Parkinson's disease.
Sources for this answer
- Neupro 2 mg/24 h Transdermal PatchUCB Pharma Limited · emc · SmPC §4.8 Undesirable effects · Version 24Document updated
Sources checked